Marcus DiPaola on MSN
Scientists create a painless vaccine patch
Researchers are testing a tiny microneedle patch that could deliver vaccines without a standard needle and early animal ...
Like many of Roland 's X0X machines, the TB-303 has had a profound effect on the development of dance music since it was released in 1981, even playing a large part in spawning its own subgenre - acid ...
A wide range of adversaries including state-sponsored actors are targeting a vulnerability in popular file extraction software WinRAR that was addressed last year. The vulnerability impacts a wide ...
Toronto, Ontario--(Newsfile Corp. - January 14, 2026) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the ...
Please provide your email address to receive an email when new articles are posted on . More children treated with the Viaskin Peanut patch vs. placebo were classified as responders at 12 months. DBV ...
DBV Technologies S.A. (NASDAQ: DBVT) on Tuesday released data from the VITESSE Phase 3 study assessing the safety and efficacy of VIASKIN Peanut patch for peanut-allergic children aged 4 to 7 years.
Topline results were announced from a phase 3 trial evaluating Viaskin ® Peanut patch in peanut allergic children aged 4 to 7 years. Viaskin Peanut patch is an epicutaneous immunotherapy that delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results